Date Published:
2015 Feb
Publication Type:
Journal Article
Authors:
Secondary:
J Leukoc Biol
Volume:
97
Pagination:
401-12
Issue:
2
PMID:
25420915
URL:
https://pubmed.ncbi.nlm.nih.gov/25420915
Keywords:
Adult;Antigens, CD;Blood-Brain Barrier;Cell Adhesion Molecules;Cell Adhesion Molecules, Neuronal;Cohort Studies;Female;Fetal Proteins;Gene Expression Regulation;GPI-Linked Proteins;HIV Infections;Humans;Inflammation;Internal;Lipopolysaccharide Receptors;Male;Middle Aged;Monocytes;Receptors, Cell Surface;Receptors, IgG;Transendothelial and Transepithelial Migration
Abstract:
<p>Monocyte transmigration across the BBB is a critical step in the development of cognitive deficits termed HAND that affect 40-70% of HIV-infected individuals, even with successful antiretroviral therapy. The monocyte subsets that enter the CNS during HIV infection are not fully characterized. We examined PBMC from HIV-positive individuals from 2 distinct cohorts and enumerated monocyte populations, characterized their transmigration properties across an in vitro human BBB model, and identified surface proteins critical for the entry of these cells into the CNS. We demonstrated that the frequency of peripheral blood CD14(+)CD16(+) and CD14(low)CD16(+) monocytes was increased in HIV-seropositive compared with -seronegative individuals, despite virologic control. We showed that CD14(+)CD16(+) monocytes selectively transmigrated across our BBB model as a result of their increased JAM-A and ALCAM expression. Antibody blocking of these proteins inhibited diapedesis of CD14(+)CD16(+) monocytes but not of T cells from the same HIV-infected people across the BBB. Our data indicate that JAM-A and ALCAM are therapeutic targets to decrease the entry of CD14(+)CD16(+) monocytes into the CNS of HIV-seropositive individuals, contributing to the eradication of neuroinflammation, HAND, and CNS viral reservoirs.</p>